The U.S. Food and Drug Administration has reported a nationwide shortage of methylphenidate (Ritalin, Methylin, and generic) and amphetamine mixed salts (Adderall and generic), stimulants commonly used to treat attention deficit hyperactivity disorder in children and adults.
FDA reports shortage of ADHD drugs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment